Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteanulex.com
CategoryBioTech
Phone952-224-4000
EmailCustomerService@a...
Employees
DescriptionDiscectomy Process Innovator

Offices

Corporate Headquarters
5600 Rowland Road
Suite 280
Minnetonka, MN, 55343
USA

People

Chief Executive Officer
Board Member
Sr. Vice President & General Manager

Funding

TOTAL $48.5M
FUNDING TOTAL $48.5M
Series C, 7/2006
MB Venture Partners
Affinity Capital Management
Split Rock Partners
New Enterprise Associates
Delphi Ventures
SightLine Partners
$20M
Series D, 5/2009
$10.2M
Series E, 6/2010
Affinity Capital Management
Delphi Ventures
MB Venture Capital Fund
New Enterprise Associates
$18.3M
DEBT TOTAL $3.78M
Debt, 3/2010
$3.78M

Tags

Anulex

Anulex Technologies is a private company located in Minneapolis, Minnesota with a focus on developing proprietary medical technology to repair and seal the soft tissue of the spine (anulus) for patients undergoing a surgical procedure to remove a herniated disc (discectomy).

Recent Milestones

  • Dollar
    Anulex received $18.3M in Series E funding. (6/7/10)
    Posted 6/7/10 at 8:44pm via onbiovc.com
  • Dollar
    Anulex received $3.78M in Debt funding. (3/17/10)
    Posted 12/16/13 at 11:28pm via sec.gov
  • Dollar
    Anulex received $10.2M in Series D funding. (5/26/09)
    Posted 6/17/09 at 11:05am via onbiovc.com
  • Dollar
    Anulex received $20M in Series C funding. (7/25/06)
    Posted 3/10/13 at 8:46pm via businesswire.com
  • Check
    Anulex added MIKE McCORMICK as President & CEO. (1/1/03)
    Posted 2/6/14 at 2:19am
  • Check
    Anulex added Tim Miller as Sr. Vice President & General Manager.
    Posted 3/10/13 at 8:01pm
  • Check
    Anulex added Jeff Peters as Chief Executive Officer.
    Posted 3/10/13 at 8:01pm

Videos

Screenshots

Anulex screenshot
Above: Anulex
Uploaded: 3/11/13

Sources

  1. Anulex Technologies, Inc. Raises $20 Million in Series C Financing (businesswire.com) [edit]
  2. Anulex Technologies, Inc.: Series D $10.2M (onbiovc.com) [edit]
  3. SEC (sec.gov) [edit]
  4. Anulex Technologies, Inc.: Series E $18.3M (onbiovc.com) [edit]
Edit This Page
Last Edited 2/6/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy